AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06087432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF Exercises
Description: Proprioceptive neuromuscular facilitation (PNF) exercises will be applied to the neck and jaw with rhythmic stabilization (RS) and combined isotonic contraction (CIC) techniques. The RS protocol consists of alternating isometric contractions for 10 seconds and does not involve movement. The KIK technique involves combined concentric, isometric and eccentric contraction of the agonist muscle without rest, with each contraction lasting 5 seconds. KIK exercises consist of 5-15 repetitions per set, depending on the individual's tolerance. Between sets, a 30-second rest will be included. First, the RS protocol will be applied and after a 2-minute rest interval, the exercise will continue with the KIK protocol applications. The expected duration of exercise exercises is 30 minutes. Maximum performance will be requested from the individual in all repetitions and the necessary verbal commands will be given for appropriate movement.
Study NCT06629441 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic group
Description: taking 10 billion CFU probiotic one sachet one time, lasting 56 days.
Study NCT06629441 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: taking maltodaxtrin one sachet one time, lasting 56 days.
Study NCT05746793 — intervention group
Intervention type: OTHER
Intervention: collection of menstrual blood
Description: collection of menstrual blood during the first day of heavy menstrual flow for at least 6 hours
Study NCT05746793 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: nutritional and metabolic work-up
Description: Including body composition analysis by BIA/whole body MRI and analysis of resting energy expenditure (REE).
Study NCT05746793 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: cardiac work-up
Description: Using transthoracic ultrasound.
Study NCT05746793 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood pressure measurement
Description: Blood pressure measurement
Study NCT04319796 — intervention group
Intervention type: OTHER
Intervention: Data set as defined by the ERN Research Workgroup of the European Commission
Description: The ERN-RND registry will be restricted to the minimum data set as defined by the ERN Research Workgroup of the European Commission. This includes the following data:~* Name of specialist center~* Pseudonym:~* Date of birth: For confidentiality reasons the ERN-RND registry will restrict this information to the Year of birth~* Sex~* Date of death: For confidentiality reasons the ERN-RND registry will restrict this information to the Year of death~* Age of onset~* Orphacode for specific rare disease: https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=DE~* Online Mendelian Inheritance in Man (OMIM) code as defined for genetic diseases: https://www.omim.org/~* Human Phenotype Ontology (HPO) terms for key features: https://hpo.jax.org/app/~* Agreement to be contacted for research purposes: Yes/No~* Biological samples (Yes / No)~* Link to a biobank (Link / No)~* Classification of disability (Disease group specific score)
Study NCT04621682 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non technical skills and checklist training in simulation
Description: using structured debrifing, in three random medical simulation crises, training in non-technical skills will be carried out
Study NCT04621682 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Checklist training simulation
Description: using structured debrifing, in three random medical simulation crises, training in checklist will be carried out
Study NCT06321913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI343 combined with IBI308
Description: IBI343 Specifications: 100 mg/bottle Approval method: TBD Q3W intravenous infusion (IV) sintilimab Specifications: 100mg (10ml)/bottle Afghan way: 200 mg Q3W IV infusion
Study NCT04648436 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Early neurosurgical hematoma evacuation
Description: Early neurosurgical hematoma evacuation (preferably within 2 hours)
Study NCT04648436 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conservative treatment (best medical management)
Description: Conservative treatment (best medical management) on the ICU or ward
Study NCT05478772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CTP-543
Description: 12 mg on Day 1 and Day 7
Study NCT05478772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: 200 mg once daily on Days 3 through to Day 8
Study NCT05436093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FDG
Description: All study participants will undergo one 18F-FDG PET/CT scan.
Study NCT04821115 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity choc waves therapy (active applicator)
Description: At each of the 4 sessions, 4000 shockwaves will be delivered at level 8 (EFD = 0.133 mJ/mm2), over a period of 15 to 20 minutes. The probe will be applied directly to the plaque, on the flaccid penis. The device will stop automatically after the 4000 shock waves.
Study NCT04821115 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham (sham applicator)
Description: At each of the 4 sessions, a sham applicator will be used. The sham applicator has an internal foam pad that disperses the shockwave energy, but is not visible from the outside. The sham applicator will look, feel and sound the same as the active, but no measurable energy is emitted.
Study NCT06306781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HCL001 cell (homologous allogeneic hepatocytes) injection
Description: The patient will undergo a DSA procedure in the hospital's operating room before infusion. A catheter will be inserted into the femoral artery and guided to the hepatic artery. Upon confirmation through imaging, HCL001 cell injection will be slowly infused through the catheter. During the infusion, the cells should be continuously agitated to prevent clumping. The infusion can be administered as a single dose or multiple doses, and after infusion, the patient will be closely monitored for at least one week.
Study NCT04743011 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin sodium
Description: Nebulized inhalation of 5 mL of a solution containing high molecular weight heparin - enriched heparin - 2.5mg/mL and 0.9% saline solution, every 4 hours for 7 days, except during the nighttime (5 doses/day)
Study NCT06322459 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sport Education Curriculum
Description: The six characteristics of The Sport Education Model include season, affiliation, formal competition, culminating event, Record-keeping, and Festivity. The intensity of the training is increasing in the first 30 minutes, and the intensity is gradually decreasing in the next 10 minutes.
Study NCT06322459 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Normal teaching
Description: The intervention content, frequency, and intensity were the same as those in the experimental group, but the type of intervention was different. The most significant difference between the two teaching methods lies in delivering basic content. The Sport Education Model includes Teacher-directed learning (10 minutes) and Team practice (10 minutes); Normal Teaching includes Teacher-directed learning (10 minutes) and Individual practice (10 minutes).
Study NCT06412302 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whey Protein+Resistance Training
Description: WP group received 25g protein on one scoop of Whey Protein Isolate (Iso100 Dymatize) with 8 weeks of resistance training 3 days a week.
Study NCT06412302 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High protein yogurt+Resistance Training
Description: PY group received 24.6g protein on two High Protein yogurts (Lonco Leche) with 8 weeks of resistance training 3 days a week.
Study NCT05022563 — intervention group
Intervention type: DRUG
Intervention: Parenteral anticoagulant
Description: Parenteral anticoagulant only
Study NCT05022563 — intervention group
Intervention type: DRUG
Intervention: Warfarin
Description: Warfarin-based
Study NCT05022563 — intervention group
Intervention type: DRUG
Intervention: Apixaban
Description: Apixaban
Study NCT05022563 — intervention group
Intervention type: DRUG
Intervention: Rivaroxaban
Description: Rivaroxaban
Study NCT05022563 — intervention group
Intervention type: DRUG
Intervention: Dabigatran
Description: Dabigatran
Study NCT05022563 — intervention group
Intervention type: DRUG
Intervention: Edoxaban
Description: Edoxaban
Study NCT05931120 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: dry needling using 50mm or 60mm sized needles based on individual muscle bulk. Targeted dry needling will be performed on the muscles presenting with tight hamstrings. hurdler Hamstring stretch, extended triangular pose 10 repetitions, 3 sets per session and 2 sessions per week for 4weeks.~total 8 sessions , each consisting of 40mins
Study NCT05931120 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IASTM
Description: Instrument assisted soft tissue mobilization tools targeting tight hamstrings. hurdler Hamstring stretch, extended triangular pose 10 repetitions, 3 sets per session and 2 sessions per week for 4weeks.~total 8 sessions , each consisting of 40mins
Study NCT04923126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirdametinib
Description: By mouth, nasogastric (NG) tube or gastrostomy tube (G-tube) BID, days 1-28
Study NCT06035484 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat height
Description: Seat height of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.
Study NCT06035484 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat inclination
Description: Seat inclination of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.
Study NCT05081336 — intervention group
Intervention type: DRUG
Intervention: Statin
Description: Statin +/- ezetimib +/- Alirocumab
Study NCT04838379 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Ninety patients were randomized to receive ultrasound-guided RSB\&tap block After the induction of anesthesia and patient stabilization, the abdomen was sterilized and draped. Then, under complete aseptic conditions, ultrasound-guided Bilateral Rectus Sheath Block \& tap block was performed
Study NCT04838379 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dexmedetomidine
Description: Ninety patients were randomized to receive ultrasound-guided RSB\&tap block After the induction of anesthesia and patient stabilization, the abdomen was sterilized and draped. Then, under complete aseptic conditions, ultrasound-guided Bilateral Rectus Sheath Block \& tap block was performed
Study NCT06412211 — intervention group
Intervention type: DEVICE
Intervention: Photoacoustic finder
Description: Sentinel lymph node detector using photoacoustic signal
Study NCT05409521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: Kinesio taping with the mechanical correction technique will be applied on the thoracic region
Study NCT05409521 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo taping
Description: Placebo taping with no tension and technique will be applied on the arm
Study NCT04743011 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Nebulized inhalation of 5 mL of 0.9% saline solution, every 4 hours for 7 days, except during the nighttime (5 doses/day)
Study NCT05856396 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Triaxis® (Pertussis-containing vaccine)
Description: Triaxis® (Pertussis-containing vaccine) will be administered:~* in non-pregnant women presenting to the Travel and Vaccine clinic for pertussis immunization only or hospital member staff requiring Tetanus Toxoid (TT)-booster immunisation~* in Pregnant women between 16 and 29 weeks of gestation.
Study NCT05856396 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Vaxelis® (Pertussis-containing vaccine)
Description: Vaxelis® (Hexavalent vaccine) will be proposed in infants at 8, 12 and 16 weeks of life.
Study NCT05815888 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lung Ultrasound Score
Description: one hemithorax is consisted of 6 scanning zones. Each of them are evaluated via ultrasonography in terms of presence of vertical B lines (\<4 B lines: 1 point; >3 B lines or thick B lines: 2 points; marked disturbance in pleural line: 3 points). Higher scores reflect worse outcomes such as atelectasis and consolidation, and totally 12 zones are evaluated.~Three different time points are defined for LUS:~T1: 5 minutes after orotracheal intubation T2: At the end of surgery, before extubation T3: 30 minutes after extubation, in postanesthesia care unit.~DeltaT= T2LUS-T1LUS~Blood gas analysis will be evaluated hourly throughout the surgery
Study NCT03314428 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gait retraining
Description: Over a 4-week period, runners will be asked to increase their step rate to reduce knee loading during running. Specifically, they will have to increase their preferred step rate by 10% during weekly laboratory running sessions as well as during habitual running training. In the laboratory, runners will be provided with live visual/auditory biofeedback on step rate and asked to target a specific value representing 110% or preferred step rate. During their individual running sessions, runners will be wearing a GPS-enabled watch that will provide feedback on live step rate, and they will be asked to maintain the same value as in the laboratory.
Study NCT06477770 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Clorhexidine soap
Description: surgical wound will be washed with saline solution and 10 ml of chlorhexidine soap
Study NCT06477770 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Clorhexidine soap
Description: surgical wound will be washed with saline solution and 10 ml of chlorhexidine soap
Study NCT06477770 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sucrose
Description: 75 g of sucrose will be administered to the surgical wound at 8:00 am every day, once a day, and then it will be covered with sterile gauze.
Study NCT06565312 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Flora Power Probiotic Vaginal Suppository
Description: The suppository contains Microcrystalline Cellulose, Ascorbic Acid, Vitamin C, Gelatin Capsule, Vaginal Probiotic Blend (Lactobacillus fermentum LF61, Lactobacillus acidophilus LA85, Lactobacillus plantarum Lp90), Magnesium Stearate, and Silicon Dioxide.
Study NCT05809947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Description: One bout of neuromuscular electrical stimulation in conjunction with forced lengthening contractions on one leg
Study NCT05809947 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Neuromuscular electrical stimulation
Description: One bout of neuromuscular electrical stimulation in conjunction with forced lengthening contractions on one leg
Study NCT05763407 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FIRE1 System
Description: FIRE1 System
Study NCT05674617 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy
Description: WET will be conducted in accordance with the Written Exposure Therapy for PTSD: A Brief Treatment Approach for Mental Health Professionals Manual and the VA evidence-based practice (EBP) rollout training.
Study NCT05674617 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PTSD Education
Description: The 5-session PTSD psychoeducation and skills protocol we will be utilizing for our PTSD education control condition was developed by PTSD clinical team (PCT) clinicians at the Washington DC VA Medical Center as a group protocol for Veterans admitted to the PCT and who were on the waitlist for individual therapy with an EBP for PTSD. The PTSD 101 protocol consists of psychoeducation on topics related to PTSD symptoms and an introduction to PTSD-related coping skills. Its duration and structure will be similar to WET (5 weekly individual 50-minute sessions). To parallel the time an attention given in individual WET sessions more closely, participants will quietly review any written materials or videos that are a part of the manualized curriculum for 30 minutes of the session, bookended by a 10-minute check-in with their provider on symptoms and introduction to new materials at the start of session and another 10-minute debrief of reviewed materials at the end of session.
Study NCT06571942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vilanterol / Umeclidinium (25/62.5 mcg)
Description: One inhalation daily from Ellipta device for three months
Study NCT05518201 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo among 18-45 yrs
Description: Subjects received 3 doses of placebo according to a 0, 2, 6-month schedule (0.5mL/each dose).
Study NCT05518201 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo among 9-17 yrs
Description: Subjects received 3 doses of placebo according to a 0, 2, 6-month schedule (0.5mL/each dose).
Study NCT05366699 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Axillary lymphadenetomy alone
Description: oncologic axillary lymphadenectomy
Study NCT06571942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg)
Description: One inhalation daily from Ellipta device for three months
Study NCT05738226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EpiCare@Home, wearable multimodal seizure monitoring system
Description: Two wearable devices (Byteflies Sensor Dots) will be used. One Sensor Dot will be placed in the neck with a skin adhesive and will be connected to EEG electrodes placed behind each ear. The second Sensor Dot will be placed on the chest with an adhesive ECG electrode (i.e., a cardiac patch).
Study NCT05574530 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Colon-delivered multivitamin supplement
Description: 6-week intervention of one dietary supplement a day, containing vitamin B2 (10mg), vitamin B3 (4mg), vitamin B6 (1.4mg), vitamin B9 (400μg), vitamin C (200mg) and vitamin D3 (15ug).
Study NCT05574530 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo supplement
Description: 6-week intervention of one dietary supplement a day, containing 200 mg of microcrystalline cellulose.
Study NCT06553560 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Parasternal Block and Recto-İntercostal Fascial Plane Block
Description: Superficial PSB is performed with the patient in the supine position using a high-frequency linear USG probe. The probe is placed longitudinally 2 cm lateral to the sternal border to visualize the T2-T4 intercostal space and to identify the pectoralis major muscle, intercostal muscle, and pleura. 10 ml of 0.25% bupivacaine local anesthetic is administered between the pectoralis major and intercostal muscle using an in-plane approach with a 100 mm needle. In addition, a Recto-Intercostal Fascial Plane Block is performed with a high-frequency linear USG probe. The probe is placed 2-3 cm lateral to the xiphoid so that the rectus abdominis muscle and 6-7th cartilages are visualized. The needle is advanced to the plane between the costal cartilage and the rectus abdominis muscle using the in-plane technique and 1-2 ml of saline is injected. After observing the spread to the target plane, 20 ml of 0.25% bupivacaine is applied. The same process is repeated bilaterally.
Study NCT06353243 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bilateral alternating stimulation
Description: positive touch intervention provided by parent to infant using alternating stimulation
Study NCT05151393 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measuring vitamin D3 level
Description: Measuring vitamin D3 in both groups
Study NCT06473402 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Muscle Strength Test
Description: Hamstring muscle strength of the participants was measured with a dynamometer (Microfet 2, Hoggan Health Industries, HHD) with the knee flexed at 90 degrees. After the physiotherapist fixes and positions the dynamometer 5 cm proximal to the calcaneus with a belt, the participant will be asked to accelerate to maximum isometric strength by trying to bring his heel closer to his hip against this resistance. The isometric strength of the hamstring muscle will be measured in Newtons (N) by being asked to wait at maximum force level for three seconds. Measurements were made in 2 repetitions and the highest value was noted. There will be a 30-second rest period between attempts.
Study NCT06473402 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Hamstring Flexibility
Description: The Sit and Reach Test will be administered to evaluate flexibility. Measurements will be made with a test stand with a length of 35 cm, a width of 45 cm and a height of 32 cm. The measurement of the participant who cannot reach the zero point of the sole of the foot on this tripod will be recorded as minus (-), while the measurement of the participant who can pass the zero point will be recorded as plus (+). Participants will be seated in a long sitting position with the soles of their feet resting on the testing apparatus, and the measurement will begin with their knee joints fully extended. While leaning his body forward, he will be asked to lie forward as far as he can, with his hands in front of his body, without bending his knees. The test will be repeated 2 times and the best value will be recorded in cm.